Good morning. While other Asian markets are enjoying some level of recovery, Macau’s outlook remains pretty grim. We reached out to Alidad Tash to go over some of the questions on the industry’s minds: Genting, Covid-zero, digital currency, and next year’s GGR outlook.
The AGB team looks forward to welcoming the industry tonight at The Peak.
What you need to know
- Alidad Tash estimates Macau’s 20023 GGR to reach about 40 percent of 2019 levels and that we won’t be getting out of a covid zero policy well into the second quarter of next year – once a made-in-China mRNA vaccine has been approved and administered to the vast majority of the Mainland’s population. In a special edition of AGB’s Face-to-Face sessions, 2NT8‘s managing director goes over some of the questions on the industry’s minds: Genting, Covid-zero, digital currency, next year’s GGR outlook.
On the radar
- Tourism boon from POGO ban speculative.
- CNMI Commission chases IPI for $25mil.
AGB Intelligence
MACAU
Not until a made-in-China mRNA vaccine
Alidad Tash estimates Macau’s 2023 GGR to reach about 40 percent of 2019 levels and that we won’t be getting out of a covid zero policy well into the second quarter of next year – once a made-in-China mRNA vaccine has been approved and administered to the vast majority of the Mainland’s population. In a special edition of AGB’s Face-to-Face sessions, 2NT8‘s managing director goes over some of the questions on the industry’s minds: Genting, Covid-zero, digital currency, next year’s GGR outlook.
Industry Updates
- Red Tiger readies Tricks and Treats slot for Halloween.
- Strong growth for NOVOMATIC at G2E in Las Vegas.
MEMBERSHIP | MAGAZINE | ASEAN | CAREERS
